Tubulointerstitial nephritis uveitis syndrome with Fanconi syndrome: Two case reports and literature review.

Jingjing Lin, Jia Sun

Journal: Medicine 2025;104(47):e46202

PMID: 41305780

Abstract

RATIONALE

Tubulointerstitial nephritis uveitis syndrome (TINU) is a rare form of acute interstitial nephritis accompanied by uveitis. However, few cases of TINU associated with Fanconi syndrome (FS) have been reported, and the clinical characteristics and optimal management of this rare association remain poorly defined.

PATIENT CONCERNS

In this case report, we aimed to describe 2 cases of TINU associated with FS and their management, emphasizing the importance of recognizing FS as a potential complication in patients with TINU.

DIAGNOSES

Two adult patients with TINU and FS were evaluated. Both presented with renal insufficiency, hypouricemia, hypophosphatemia, hypokalemia, renal glycosuria, low-molecular-weight proteinuria, and uveitis. One patient also had renal tubular acidosis. Renal biopsy revealed acute interstitial nephritis in both cases, with one case additionally showing immunoglobulin A nephropathy.

INTERVENTIONS/OUTCOMES

Systemic and ocular topical corticosteroids were administered, and potassium citrate was used to correct renal tubular acidosis. Renal function, electrolyte levels, and urinalysis results normalized in both patients.

LESSONS

In patients with TINU and renal tubular dysfunction (such as low-molecular-weight proteinuria, hypophosphatemia, and hypouricemia) the possibility of secondary FS should be considered. Along with corticosteroid therapy, timely treatment of renal tubular acidosis is essential.

Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.

Address: Department of Nephrology, Linping Campus, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.